Press Releases

Month Year

Month Year

Mar 10, 2009

Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND

Read more
Feb 26, 2009

Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call

Read more
Feb 12, 2009

Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

Read more
Jan 21, 2009

Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants

Read more
Dec 26, 2008

Insmed to Appeal Delisting Notification From Nasdaq

Read more
Dec 23, 2008

Insmed Announces that NASDAQ Extends Temporary Suspension of Minimum Bid Closing Price Rule

Read more
Nov 25, 2008

Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference

Read more
Nov 18, 2008

Insmed to Participate in Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for Competition and Continued Innovation

Read more
Nov 10, 2008

Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs

Read more
Nov 5, 2008

Insmed to Present at Upcoming Healthcare Conferences

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation